Regenerative medicine in Huntington's disease: Current status on fetal grafts and prospects for the use of pluripotent stem cell
- 1 December 2014
- journal article
- research article
- Published by Elsevier in Revue Neurologique
- Vol. 170 (12) , 749-762
Abstract
No abstract availableKeywords
Funding Information
- French National Research Agency (ANR-2010-RFSC-003)
- Investment for the future (ANR-11-INBS-0011)
This publication has 88 references indexed in Scilit:
- Human Embryonic Stem Cell-Derived GABA Neurons Correct Locomotion Deficits in Quinolinic Acid-Lesioned MiceCell Stem Cell, 2012
- Embryonic stem cell trials for macular degeneration: a preliminary reportThe Lancet, 2012
- Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s diseaseNature, 2011
- Human Pluripotent Stem Cell Therapy for Huntington's Disease: Technical, Immunological, and Safety ChallengesNeurotherapeutics, 2011
- Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point MutationsCell, 2011
- Targeted Gene Correction of Laminopathy-Associated LMNA Mutations in Patient-Specific iPSCsCell Stem Cell, 2011
- Mouse models of Huntington's disease and methodological considerations for therapeutic trialsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cellsNature, 2009
- A patient with Huntington’s disease and long-surviving fetal neural transplants that developed mass lesionsActa Neuropathologica, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007